Article    Table of Contents                    Full Text of this article Free    PDF of this article (PDFs free after 6 months)    Summary for Patients    Summary for Patients (PDF)    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Khan, L. K.    Williamson, D. F.    Related Articles in PubMed    PubMed Citation    PubMed

BRIEF COMMUNICATION

Use of Prescription Weight Loss Pills among U.S. Adults in 1996–1998

Laura Kettel Khan, PhD; Mary K. Serdula, MD; Barbara A. Bowman, PhD; and David F. Williamson, PhD

20 February 2001 | Volume 134 Issue 4 | Pages 282-286

Background: Pharmacotherapy is recommended for the treatment of obese persons with a body mass index of 30 kg/m² or higher or a body mass index of at least 27 kg/m² plus an obesity-related comorbid condition.

Objective: To estimate the prevalence of use of prescription weight loss pills in the United States in 1996–1998.

Design: 1998 Behavioral Risk Factor Surveillance System, a nationally representative telephone survey.

Setting: United States.

Participants: 139 779 adults 18 years of age and older.

Measurements: Self-reported pill use for 1996–1998, body mass index (current and before pill use), age, sex, and race or ethnicity.

Results: The 2-year prevalence of pill use was 2.5% (95% CI, 2.1% to 2.9%), or 4.6 million U.S. adults. Use was higher in women than in men (4.0% vs. 0.9%, respectively) and highest among Hispanic respondents (3.2%). Of pill users, 25% were not overweight (body mass index < 27 kg/m² before using pills.

Conclusions: Nearly 5 million U.S. adults used prescription weight loss pills in 1996–1998. However, one quarter of users were not overweight, suggesting that weight loss pills may be inappropriately used, especially among women, white persons, and Hispanic persons.

Author and Article Information

From the Centers for Disease Control and Prevention, Atlanta, Georgia.

Requests for Single Reprints:Laura Kettel Khan, PhD, Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop K26, Atlanta, GA 30341; e-mail, LDK7{at}cdc.gov.

Current Author Addresses:Drs. Khan, Serdula, and Bowman: Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop K26, Atlanta, GA 30341.

Dr. Williamson: Division of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop K26, Atlanta, GA 30341.

Author Contributions:Conception and design: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson.

Analysis and interpretation of the data: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson.

Drafting of the article: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson.

Critical revision of the article for important intellectual content: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson.

Final approval of the article: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson.

Provision of study materials or patients: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson.

Statistical expertise: L.K. Khan.

Related articles in Annals:

Summaries for Patients
Use of Prescription Weight Loss Pills by U.S. Adults in 1996–1998

Annals 2001 134: S81. [Full Text]  

This article has been cited by other articles:

				J. R. Berger The Neurological Complications of Bariatric Surgery Arch Neurol, August 1, 2004; 61(8): 1185 - 1189. [Full Text] [PDF]

				G. Reaven, F. Abbasi, and T. McLaughlin Obesity, Insulin Resistance, and Cardiovascular Disease Recent Prog. Horm. Res., January 1, 2004; 59(1): 207 - 223. [Abstract] [Full Text]

				J.D. Kleinke Access Versus Excess: Value-Based Cost Sharing For Prescription Drugs Health Aff., January 1, 2004; 23(1): 34 - 47. [Abstract] [Full Text] [PDF]

				T. McLaughlin, F. Abbasi, K. Cheal, J. Chu, C. Lamendola, and G. Reaven Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant Ann Intern Med, November 18, 2003; 139(10): 802 - 809. [Abstract] [Full Text] [PDF]

				S. Liu, W. C Willett, J. E Manson, F. B Hu, B. Rosner, and G. Colditz Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women Am. J. Clinical Nutrition, November 1, 2003; 78(5): 920 - 927. [Abstract] [Full Text] [PDF]

				R. S. Stafford and D. C. Radley National Trends in Antiobesity Medication Use Arch Intern Med, May 12, 2003; 163(9): 1046 - 1050. [Abstract] [Full Text] [PDF]

				S. Z. Yanovski and J. A. Yanovski Obesity N. Engl. J. Med., February 21, 2002; 346(8): 591 - 602. [Full Text] [PDF]

				W.-T. Kong, S.-S. Chua, and S. Alwi Weight Loss Practices Among Malaysian Adults Asia Pac J Public Health, January 1, 2002; 14(2): 99 - 104. [Abstract] [PDF]

				D. Arterburn and P. H. Noel Extracts from ""Clinical Evidence"": Obesity BMJ, June 9, 2001; 322(7299): 1406 - 1409. [Full Text] [PDF]

				Inappropriate Use of Pharmacotherapy for Obesity Journal Watch (General), March 6, 2001; 2001(306): 3 - 3. [Full Text]